Functional assays using MEK inhibitors indicated that MEK and ERK phosphorylation is necessary for caspase-3 activation by cisplatin either in p53wt or in p53null human teratocarcinoma cell lines [104]. Here, MAP2K7 is linked to teratocarcinoma.